Literature DB >> 19506025

Clinical responses to a mega-dose of vitamin D3 in infants and toddlers with vitamin D deficiency rickets.

Ashraf T Soliman1, Mohamed El-Dabbagh, Ashraf Adel, Maryam Al Ali, Elsaid M Aziz Bedair, Rania K Elalaily.   

Abstract

OBJECTIVES: Was to investigate the effect of treatment with an IM injection, a mega dose of vitamin D3 (10,000 IU/kg) on the clinical, biochemical and radiological parameters of 40 rachitic children with vitamin D deficiency (VDD) over a period of 3 months.
DESIGN: In this prospective study we evaluated the clinical, biochemical and radiological responses of an IM injection of cholecalciferol (10,000 IU/kg) for 3 months.
RESULTS: At presentation, the most frequent manifestations were enlarged wrist joints, hypotonia, irritability, cranial bossing, wide anterior fontanel, bow legs, delayed teething and walking and Harrison's sulcus with chest rosaries. Short stature (length SDS < -2) was recorded in 30% of patients. Craniotabes and hypocalcemic tetany were the least common presentations. In VDD children the most frequent biochemical abnormality was high alkaline phosphatase (ALP) (100%), followed by low phosphate (PO(4)) (75%) and low calcium (Ca) (12.5%). One month after treatment, serum Ca, PO(4) and 25(OH)D concentrations were normal. Three months after the injection, serum level of ALP and parathormone (PTH) decreased to normal. The majority of patients (87.5%) had serum 25(OH)D level >or= 20 ng/ml, but some (12.5%) had level <20 ng/ml. Hypercalcemia was not recorded in any patient during the 3-month-period. Significant cure of all symptoms and signs related to vitamin D deficiency had been achieved in all children. Leg bowing showed significant improvement in all patients but was still evident in one third. Complete healing of the radiological evidence of rickets was achieved in 95% of all children.
CONCLUSION: An IM injection of a mega dose of cholecalciferol is a safe and effective therapy for treatment of VDD rickets in infants and toddlers with normalization of all the biochemical parameters and healing of radiological manifestations. Measurement of serum 25(OH)D level is highly recommended in all short children with a clear need for a general vitamin D supplementation for all infants and young children in Qatar.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506025     DOI: 10.1093/tropej/fmp040

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  15 in total

1.  Strategies to defeat ketamine-induced neonatal brain injury.

Authors:  C P Turner; S Gutierrez; C Liu; L Miller; J Chou; B Finucane; A Carnes; J Kim; E Shing; T Haddad; A Phillips
Journal:  Neuroscience       Date:  2012-02-23       Impact factor: 3.590

2.  Rachitic changes, demineralization, and fracture risk in healthy infants and toddlers with vitamin D deficiency.

Authors:  Jeannette M Perez-Rossello; Henry A Feldman; Paul K Kleinman; Susan A Connolly; Rick A Fair; Regina M Myers; Catherine M Gordon
Journal:  Radiology       Date:  2011-11-21       Impact factor: 11.105

Review 3.  Vitamin D deficiency in a tropical country--treatment and prevention in children.

Authors:  Kriti Joshi; Vijayalakshmi Bhatia
Journal:  Indian J Pediatr       Date:  2013-11-06       Impact factor: 1.967

Review 4.  Vitamin D deficiency in surgical congenital heart disease: prevalence and relevance.

Authors:  James Dayre McNally; Kusum Menon
Journal:  Transl Pediatr       Date:  2013-07

5.  Randomised Controlled Trial Comparing Daily Versus Depot Vitamin D3 Therapy in 0-16-Year-Old Newly Settled Refugees in Western Australia Over a Period of 40 Weeks.

Authors:  Ushma Wadia; Wayne Soon; Paola Chivers; Aesen Thambiran; David Burgner; Sarah Cherian; Aris Siafarikas
Journal:  Nutrients       Date:  2018-03-13       Impact factor: 5.717

6.  Comparative Effectiveness of a Six-Week Treatment Course of Vitamin D2 and D3 in Children With Sickle Cell Anemia in Steady State With Hypovitaminosis D: A Randomized Clinical Trial.

Authors:  Motunrayo Oluwabukola Adekunle; Adeyemi Oluwaseun Dada; Fidelis Olisamedua Njokanma; Adaobi Uzoamaka Solarin; Barakat Adeola Animasahun; Moriam Omolola Lamina
Journal:  J Hematol       Date:  2021-06-16

Review 7.  Vitamin d status in thalassemia major: an update.

Authors:  Ashraf Soliman; Vincenzo De Sanctis; Mohamed Yassin
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

8.  Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes.

Authors:  Darina Bassil; Maya Rahme; Maha Hoteit; Ghada El-Hajj Fuleihan
Journal:  Dermatoendocrinol       Date:  2013-04-01

9.  Adaptation to vitamin D deficiency: Age specific clinical presentations.

Authors:  Ashraf Soliman; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2013-09

Review 10.  Prevalence of vitamin d insufficiency in qatar: a systematic review.

Authors:  Alaa Badawi; Paul Arora; Eman Sadoun; Al-Anoud Al-Thani; Mohamed H Al Thani
Journal:  J Public Health Res       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.